The 2025 FAST Science Summit brought together leading researchers, scientists, clinicians, industry experts and members of the Angelman syndrome community for an important event dedicated to advancing research and accelerating progress towards potential treatments.
The summit provided an opportunity to hear directly from those at the forefront of Angelman syndrome research, with presentations covering the latest scientific discoveries, developments in therapeutic approaches, ongoing clinical trials and the challenges involved in bringing new treatments from the laboratory into clinical development.
A key focus of the event was the progress being made towards understanding and addressing the underlying genetic causes of Angelman syndrome. Researchers shared insights into emerging treatment strategies, advances in clinical research and the work being undertaken to better understand how potential therapies could improve the lives of individuals living with the condition.
Alongside the scientific presentations, the summit highlighted the vital role of families, caregivers and the wider Angelman syndrome community in shaping research priorities, supporting clinical trial development and ensuring that the experiences and needs of individuals with Angelman syndrome remain central to scientific progress.
For families navigating the rapidly developing research landscape, the summit offered valuable information about current developments, what different stages of clinical research involve and the steps that may still be needed before promising treatments become widely available.
Watch the presentations and catch up on the discussions from the 2025 FAST Science Summit to gain a deeper understanding of the research underway, the progress being made and the ongoing international effort to develop meaningful treatments for Angelman syndrome.